A webinar presentation byKim Witczak, who serves as the consumer representation on the FDA’s psychopharmacologic advisory committee. In her talk, she tells of systemic flaws, shedding light on industry and regulatory priorities, and exposes the intricate web of influence driven by marketing agendas and profit motives, often unbeknownst to doctors and patients alike.
See presentation here.
